You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Uzbekistan

Aug 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health becomes more mature

Consumer health in Uzbekistan continued to develop in 2011, with several favourable factors impacting sales. These included social, economic, demographic and marketing factors, including interaction between companies, their distributors and consumers. Based on consumers’ perception about consumer health products, some categories are highly developed, whilst others are only just emerging. In such cases, operators’ input is seen as an invaluable contribution to moving sales forward. Overall, the consumer health market continues to advance towards maturity.

The market gains from stability and the growing consumer base

In 2011 the performance of overall consumer health was positive. Major trends impacting sales remained stable, including trends in retailing and distribution, as well as consumer behaviour, which had a respective impact on sales. On the other hand, the consumer base continued to increase, stimulating higher growth. Growth in the population was especially valuable in certain categories, which directly depend on certain key consumer groups.

Imports lead, whilst domestic companies strengthen their capacity

Consumer health is mainly driven by sales of imports. Imports establish the main trends, and are responsible for the most innovative approaches and new product developments. Meanwhile, the potential of domestic companies is also growing. This can be seen in the growing skills and capabilities of domestic companies in terms of production capacity, marketing abilities and product novelties.

Strict government regulation limits sales mainly to chemists/pharmacies

Regardless of under the counter or over the counter rules, major consumer health products, including non-Rx products, are subject to sale through chemists/pharmacies. This creates a unique opportunity for this channel. Because chemists/pharmacies is the main channel through which consumers address their health concerns, products which are not purely medical, such as wound care and herbal/traditional products, are also purchased through this channel.

Anticipated stability is expected to generate positive growth

The consumer health market enjoys strong consumer loyalty, as well as many ongoing external influencing factors, such as marketing campaigns and the development of domestic production. Such stable trends, along with the growing consumer base, promise constant growth in sales of consumer health products. Every category within the consumer health market will have its own development path; however, the overall performance of the market in the forecast period is expected to be confident.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Uzbekistan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Uzbekistan, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Uzbekistan for free:

The Consumer Health in Uzbekistan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Uzbekistan?
  • What are the major brands in Uzbekistan?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Uzbekistan - Industry Overview

EXECUTIVE SUMMARY

Consumer health becomes more mature

The market gains from stability and the growing consumer base

Imports lead, whilst domestic companies strengthen their capacity

Strict government regulation limits sales mainly to chemists/pharmacies

Anticipated stability is expected to generate positive growth

KEY TRENDS AND DEVELOPMENTS

The government continues with strong healthcare programmes, and consumers’ health concerns steadily rise

Based on the comparatively young population of Uzbekistan, the demand for paediatric products increases

Thanks to government incentives the number of private medical centres increases, which leads to opportunities for manufacturers

As one of the most developed segments within overall advertising, advertisements for consumer health products trigger sales

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Uzbekistan - Company Profiles

Asklepiy Pharmaceutical Co in Consumer Health (Uzbekistan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

JV Jurabek Laboratories Ltd in Consumer Health (Uzbekistan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Pharmed Pharmaceutical Co in Consumer Health (Uzbekistan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care is not developed in Uzbekistan. However, this does not reflect the real potential of the category, as Uzbek consumers face challenges related to oral/mouth problems. The main reason preventing massive sales is poor development of supply, and the extremely high prices of existing products.

SWITCHES

COMPETITIVE LANDSCAPE

  • In terms of the competition, adult mouth care is dominated by six major companies and their brands. Unique Pharmaceutical Laboratories was the most successful company in 2011, since its Metrogil brand led with a 20% share of value sales. This success was due to the variety of product types and formats offered under the Metrogil brand: including gels, liquids, pastes and tablets.

PROSPECTS

  • Adult mouth care has good potential for growth. During the forecast period domestic production is expected to see an improvement in quality, which will help to increase volume sales, but will generate lower value growth due to the low prices of such products. As a result the category is expected to see a negligible CAGR in constant value terms in the forecast period.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Analgesics, as one of the core categories for self-medication, continued to benefit from consumers’ self-treatment activities. Representing a mandatory item in first aid boxes in homes, cars and organisations, analgesics are consumed for unexpected pain, and therefore in most cases not necessarily based on a doctor’s recommendation. Moreover, in 2011 the scale of advertisements for analgesics increased, having more influence on consumers’ habits and perceptions. These two factors are seen as the main forces driving sales of analgesics in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 analgesics witnessed small changes in the competitive landscape compared with 2010. Bristol-Myers Squibb lost 1%, however managed to hold leading position with a 31% share of retail value sales of analgesics. The company maintained its leading position thanks to strong consumer loyalty to its major brands Efferalgan (15%) and Fervex (14%). GlaxoSmithKline remained second in analgesics with a 20% share of value sales in 2011, based on its Panadol (9%), Coldrex (6%) and Solpadeine (4%) brands. GlaxoSmithKline enjoys popularity for its Coldrex brand, and benefits from the comparatively higher price of Solpadeine, which generates higher retail value sales.

PROSPECTS

  • Analgesics is expected to increase by a CAGR of 1% in constant value terms in the forecast period. This is based on expected stability of current trends. As the main background, the consumer base will continue to strengthen thanks to steady population growth. On the other hand, analgesics will be impacted by the growing influence of traditional methods of pain relief, including non-manufactured herbal products. Overall growth is expected to remain positive over the forecast period.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Historically, calming and sleeping products were considered mainly for sleeping purposes. However, thanks to active marketing campaigns and doctors’ recommendations, calming and sleeping products are now also widely consumed as a remedy for stressful and hectic lifestyles. On the one hand this is a reflection of the growing intensity of consumers’ lives, especially amongst young entrepreneurs and students. On the other hand this is also the result of continuous marketing campaigns from operators. This contributed to growing consumer awareness about the usefulness and attractive features of calming and sleeping products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ivax Corp led calming and sleeping with the Novo-Passit brand in 2011, accounting for a 27% share of value sales. Uzkhimpharm was the second company, with the generic Dimedrol brand. Glicin from Biotiki MNPK replaced Donornil from Bristol-Myers Squibb in third position with a 13% share of value sales in 2011, whilst Donomil itself was positioned fourth with an 11% value share. Other major brands in calming and sleeping were Biopassit from Unique Pharmaceutical Laboratories (6% share) and Persen Forte from Lek Pharmaceuticals (5% share).

PROSPECTS

  • Sales of calming and sleeping products are expected to strengthen over the forecast period, thanks to the growing consumer habit of using such products, brand loyalty, and consumption on a more frequent basis. On the other hand, the number of consumers who tend to consume such products to balance their emotions is also expected to rise.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2006-2011
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 25 Calming and Sleeping Company Shares 2007-2011
  • Table 26 Calming and Sleeping Brand Shares 2008-2011
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies represents one the most developed categories in OTC products, accounting for more than a third of overall value sales. Strong sales can mainly be explained by objective factors, such as the climate in Uzbekistan. The dry climate in the country creates favourable conditions for the spread of coughs, colds and allergies. Regardless of the time of year, consumers frequently suffer from such problems, creating stable demand. This continued in 2011, which generated stable 11% current value growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 cough, cold and allergy (hay fever) remedies witnessed a change of leader. Although the shares of Berlin-Chemie and Nycomed Pharma were almost equal over the last three years, in 2011 Nycomed Pharma took advantage of its marketing campaigns and took the leading position, with a 30% share of value sales. Berlin-Chemie, with its Bromhexin and Falimint brands, was second with a 28% share of value sales. The success of both companies is due to well-developed promotional strategies, a historically long presence, which leads to strong consumer loyalty, and comparatively affordable prices.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is expected to remain one of the most developed categories in OTC products. Sales will continue to grow thanks to stability of trends, such as the growing consumer base and adverse climate conditions (favourable to the development of coughs, colds and allergies). In addition, companies are expected to maintain their marketing activities. Meanwhile, the influence of domestic products is also expected to grow, whilst imports will start to lose share. This will cause a shift towards lower-priced products, which assumes the generation of lower retail sales. In line with such opposing factors, cold, cough and allergy (hay fever) remedies is expected to see a low constant value CAGR of 1% over the forecast period.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Bulky, oily and calorie-laden Uzbek food often causes digestive problems. There are several events and factors which make the national cuisine so adverse to the digestive system. These include morning pilaffs, Uzbek traditional food which is served during weddings and other important celebrations as early as 05:00hrs, or regular meetings called gap – which means “chat”, and describes a monthly or once-a-fortnight gatherings of groups of men or women. Considering these events involve the consumption of oily food in large quantities, all such events result in overeating and digestive disorders in the long term.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 Berlin-Chemie strengthened its sales and leading position in digestive remedies, reaching a 36% share of overall value sales. Its strong share is attributable to successful sales of its Mezym Forte and Espumizan brands. Both brands have amongst the strongest marketing campaigns on domestic TV channels, which contributed to improving consumer awareness and knowledge about the products. Sanofi accounted for the second highest sales in 2011, holding a 31% share of overall value sales. Its strong position is supported by its large brand portfolio, including Festal, Maalox and No-spa.

PROSPECTS

  • Neither Uzbek cuisine nor traditional eating behaviour is expected to change over the forecast period; therefore the category will enjoy stability of existing trends over the coming years. The problems caused by oily and high-calorie Uzbek food are not expected to disappear, considering Uzbek consumers lead less active lifestyles, including little sport.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 37 Digestive Remedies Company Shares 2007-2011
  • Table 38 Digestive Remedies Brand Shares 2008-2011
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Ear problems have traditionally not been considered as a serious illness amongst adults. Observation of the market shows that unlike in eye care, many adult consumers do not suffer from ear problems. However, in the case of children the situation dramatically changes, based on the low tolerance of children to ear problems. Therefore, as a rule, every family with children keeps ear care products in their family medical box. Based on the key end-users, sales of ear care products depend on the number of children in society, and as such remain stable. Ear care increased by 3% in current value terms in 2011, accounting for sales of UZS3.4 billion.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi led ear care in 2011 with its Sofradex brand. It accounted for a 50% share of value sales. Bornaya Kislota, as the generic product of domestic company Uzkhimpharm, is also popular, but due to its comparatively cheaper price, the company’s share reached only 15% in 2011. Other brands with major shares in 2011 were Aurisan Kapli from Ukrmedprom and Otinum Kapli from ICN Pharmaceutical, holding 6% and 4% value shares respectively.

PROSPECTS

  • The problems related to product supply in ear care are expected to recover over the forecast period. Besides, operators will become more active in terms of promoting their products. Consumption will be generated not only by consumers themselves when they suffer from ear problems or pain, but marketing campaigns will also create stronger demand, both improving the trend of self-medication and consumers’ knowledge about ear problems, and the necessity of addressing such problems to medical staff. For this reason, constant value sales of ear care products are expected to see positive growth towards the end of the forecast period. However, overall, a negative constant value CAGR of 1% is still expected in the forecast period.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2006-2011
  • Table 42 Sales of Ear Care: % Value Growth 2006-2011
  • Table 43 Ear Care Company Shares 2007-2011
  • Table 44 Ear Care Brand Shares 2008-2011
  • Table 45 Forecast Sales of Ear Care: Value 2011-2016
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Uzbekistan - Category Analysis

TRENDS

  • Emergency contraception has negligible sales in Uzbekistan, and no data is available

Eye Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • The traditionally dry climate in Uzbekistan has always had an adverse effect on people’s eyes. However, in line with the improvement in consumers’ living standards, the number of air conditioners is growing. Considering that Uzbek consumers are not familiar with air moisteners and these are not widely used, many such consumers have red eye and dry eye symptoms and other eye problems.

SWITCHES

COMPETITIVE LANDSCAPE

  • Little changed in the competitive landscape in eye care in 2011 compared with the previous year: companies maintained their positioning, there were no major gains or losses in share, and no new entrants in the category. These factors reflect the stable positioning of all brands, and consumers’ established preferences and choices. The absence of any direct marketing campaigns made the situation even more dependent on purchasing traditions and consumer habits, rather than operators’ activities.

PROSPECTS

  • Because there is no strong marketing of eye care products, sales are expected to be based on consumers’ pure (not influenced) demand. The number of consumers suffering from eye problems is growing, and the potential continues to expand; however, despite this, the absence of any marketing and educational tools prevents consumers from addressing their eye-related concerns to medical staff or directly using eye care products for self-medication. Such limited consumption will keep the constant value growth rate at only a negligible CAGR over the forecast period.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2006-2011
  • Table 48 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 49 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 50 Standard Eye Care by Positioning 2007-2011
  • Table 51 Eye Care Company Shares 2007-2011
  • Table 52 Eye Care Brand Shares 2008-2011
  • Table 53 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products continue to gain popularity thanks to marketing promotions from manufacturers. Noticeably, consumers are positively reacting to claims such as “natural/herbal ingredients”, which are widely being used to compete against other non-herbal products. Such marketing campaigns helped sales to increase by 15% in 2011.

COMPETITIVE LANDSCAPE

  • Novo-Passit from Ivax Corp remained the leader in herbal/traditional products in 2011, accounting for a 24% value share. As calming and sleeping herbal/traditional products accounted for a 58% share of overall value sales, Novo-Passit’s leadership was a reflection of this dominance. Bronchicum from Sanofi followed with a 19% share of value sales in 2011.

PROSPECTS

  • Herbal/traditional products is expected to maintain its strong potential. Thanks to consumers’ positive feedback and perceptions, herbal/traditional products will be attractive to them, and sales are expected to increase by a CAGR of 2% in constant value terms over the forecast period.

CATEGORY DATA

  • Table 55 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 56 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 57 Herbal/Traditional Products Company Shares 2007-2011
  • Table 58 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 59 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 60 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care continued to develop in 2011, thanks to various factors positively influencing sales. These included the strengthening distribution of products to a wider area, as well as the wide presence of products in almost all categories, and demographic growth, which contributed to a larger consumer base.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson led medicated skin care with a 17% value share in 2011 with its Johnson’s Baby and Nizoral brands, whilst in terms of brand performance, Radiks from Radiks NPP led with a 16% share. The reasons behind the leadership of these brands are well-organised distribution, and, most importantly, competitive prices.

PROSPECTS

  • Medicated skin care is expected to continue to see positive growth in the forecast period. This forecast is based on stability of current trends and the absence of any significant threat to growth which would hinder sales. However, such stability will also prevent any drastic increase in sales over the forecast period. Medicated skin care is projected to see a CAGR of 1% in constant value terms in the forecast period.

CATEGORY DATA

  • Table 61 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 62 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 63 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 64 Medicated Skin Care Brand Shares 2008-2011
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Uzbekistan - Category Analysis

TRENDS

  • NRT smoking cessation aids are not present in Uzbekistan. Because the number of smokers is extremely high, smoking is considered everyday and ordinary, and is not criticised or considered a bad thing. The number of smokers interested in giving up is small, and even those who are intending to do so are not expected to use NRT smoking cessation aids.

Sports Nutrition in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition is very underdeveloped in Uzbekistan. The main reason is that the general public has a negative perception about such products, whilst existing consumption is limited to selected sportspeople. Consumers with a negative attitude believe these products are unnatural, and a form of doping. Meanwhile, sportspeople who consume them are usually professionals; only practising athletes, swimmers and boxers.

COMPETITIVE LANDSCAPE

  • The competitive positioning in sports nutrition did not witness any changes in 2011. All brands and companies saw similar growth rates, in line with the development of the overall category.

PROSPECTS

  • Practising sport is popular in Uzbekistan, and physical exercise is strongly encouraged by the government. However, the popularity of sport is not yet related to the development of sports nutrition products. With the government’s support, the number of gyms and sports centres has significantly increased across the country, including in rural areas. Meanwhile, the consumption of sports nutrition products occurs only based on encouragement by individual/private trainers through private gyms and certain individual sports centres in Tashkent city. Considering the limited number of such outlets and the low popularity of sports nutrition in other sports establishments, products in the category do not have enough potential to grow or expand.

CATEGORY DATA

  • Table 67 Sales of Sports Nutrition: Value 2006-2011
  • Table 68 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 69 Sports Nutrition Company Shares 2007-2011
  • Table 70 Sports Nutrition Brand Shares 2008-2011
  • Table 71 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 72 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Sales of vitamins and dietary supplements continued to rise in 2011, thanks to the joint effects of several trends. First of all, manufacturers and distributors in Uzbekistan are active in marketing their products. This includes both direct advertisements and promotional campaigns through cooperation programmes with medical staff. In addition, the number of children and pregnant women, who are key consumers of vitamins and dietary supplements, continued to rise. This strengthened the potential of products in the category.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • In terms of the competitive positioning of companies, Krka dd Novo Mesto with its two brands Duovit and Pikovit led vitamins and dietary supplements in 2011, holding an 18% value share. Its leading share was generated by successful sales of these two brands in multivitamins. In terms of brand performance, Vitrum from Unipharm was the leader, reaching a 16% share of value sales. Vitrum’s leadership can be attributed to its presence in various formats and amongst various consumer groups: younger children, older children, pregnant women, those with calcium deficiency and others.

PROSPECTS

  • Vitamins and dietary supplements is expected to continue growing thanks to strengthening consumer potential, along with the growing number of pregnant women and children in society. Besides, consumers’ overall living standards are expected to rise, creating stronger purchasing potential. In addition, the ongoing marketing campaigns of manufacturers will generate higher consumer awareness, and respectively more demand, whilst doctors’ recommendations will be beneficial in terms of driving sales of certain brands. Overall, based on these positive trends, vitamins and dietary supplements is forecast to see a CAGR of 3% over the next five years.

CATEGORY DATA

  • Summary 6 Dietary Supplements: Brand Ranking by Positioning 2011 
  • Table 73 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 74 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 75 Dietary Supplements by Positioning 2007-2011
  • Table 76 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 77 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 78 Vitamins Brand Shares 2008-2011
  • Table 79 Dietary Supplements Brand Shares 2008-2011
  • Table 80 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 81 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Weight management is very poorly developed in Uzbekistan, and only accounted for sales of UZS7 million in 2011. The reason is the absence of official sales and weak supply. On the other hand, low sales reflect low consumer demand for, and interest in, these products. In general, consumers in Uzbekistan do not suffer from being overweight. However, even if this is a problem, then gaining weight by the age of 40 is considered natural amongst Uzbek women, whilst in case of men it is not a concern at all.

COMPETITIVE LANDSCAPE

  • There are several operators responsible for sales of weight management products in Uzbekistan. There are four major producers of weight loss supplements and two major producers of slimming teas. A 25% share of value sales was held by Abbott Laboratories in 2011, followed by Shenzhen Taitai Pharmaceutical – another producer of weight loss supplements – holding a 20% share of sales. Leovit-Nutrio and Bional International were the next two major companies, and Fitera and Yangshengtang were the only major companies in slimming teas.

PROSPECTS

  • There is no existing or forecast strong potential for weight management in Uzbekistan. This is mainly due to consumers’ eating habits, which it is unlikely will change over the forecast period. Consumers’ perceptions are not expected to change regarding weight, although Uzbek consumers do not generally suffer from extreme obesity or from being overweight.

CATEGORY DATA

  • Table 82 Sales of Weight Management by Category: Value 2006-2011
  • Table 83 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 84 Weight Management Company Shares 2007-2011
  • Table 85 Weight Management Brand Shares 2008-2011
  • Table 86 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 87 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Wound care continues to generate steady growth, due to the necessity of such products on a regular basis in the daily lives of consumers. Because of the absence of institutional supplies or limited such possibilities, consumers now have to purchase wound care products themselves, compared with free-of-charge supply by medical organisations in past. This was the main factor driving sales of wound care products, which in 2011 recorded 9% growth in current value terms.

COMPETITIVE LANDSCAPE

  • Sarbontex remained the leader in wound care with a 33% share of value sales in 2011. Its success can be attributed to several reasons. Sarbontex is a local company, and is therefore able to offer products at lower prices than any other multinational company. In addition, the company is capable of offering high-quality products, which helps it to maintain customer satisfaction. The third reason is the strong distribution that Sarbontex has established in country.

PROSPECTS

  • Wound care is forecast to record a CAGR of 1% in constant value terms in the forecast period, mainly thanks to the stability of current trends. The key consumers of wound care products are not expected to change significantly, institutional free supplies are not expected to develop again, and companies will continue to offer various attractive products to stimulate sales.

CATEGORY DATA

  • Table 88 Sales of Wound Care by Category: Value 2006-2011
  • Table 89 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 90 Wound Care Company Shares 2007-2011
  • Table 91 Wound Care Brand Shares 2008-2011
  • Table 92 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 93 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!